FDA approves 10% fewer new drugs in 2026 vs. 2028

Regulatory uncertainty under the delayed commissioner appointment will slow drug approvals by 10% year-over-year. This will be driven by cautious reviews and reduced staffing efficiency at the FDA.

Implied probability (Yes)

65%

Closes

2028-12-31